D. F. Badenoch
Royal London Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by D. F. Badenoch.
The Journal of Urology | 1991
J. P. Blandy; D. F. Badenoch; C. G. Fowler; B. J. Jenkins; N.W.M. Thomas
Contrary to the traditional doctrine of delayed intervention in post-hysterectomy injuries of the ureter or bladder, the policy at our department has been to operate as soon as possible after the diagnosis is made. Of 68 patients (25 with vesicovaginal fistulas and 43 with ureteral injuries) early intervention was possible in 40 (59%). Primary healing was obtained in all patients. These results suggest that there is no disadvantage in early repair.
The Journal of Urology | 1999
R. Ravi; J. Ong; R.T.D. Oliver; D. F. Badenoch; C. G. Fowler; W.F. Hendry
OBJECTIVE To review our experience of surgical staging for residual masses after chemotherapy in patients with nonseminomatous germ cell tumour (NSGCT) and positive tumour markers. PATIENTS AND METHODS Of 107 patients with metastatic NSGCTs treated surgically after chemotherapy from 1978 to 1995, 30 (median age 30.5 years, range 20-52) had positive tumour markers. These patients were reviewed and the outcome compared with 77 patients who had normal tumour marker values. RESULTS Of the 77 patients with negative markers undergoing surgical/pathological staging, 71 (92%) became continuously disease-free, including 37 of 50 (74%) with viable NSGCT in excised specimens. Seventeen of 30 (57%) with raised marker levels undergoing similar surgery for chemotherapy-resistant tumour became disease-free, including 11 of 22 with viable NSGCT in the excised specimens. CONCLUSION Although the outcome after surgery is better in patients with negative tumour markers, it is clear that surgery is curative for patients with localized chemotherapy-resistant masses. There is a need for continued debate on the timing of salvage surgery and subsequent chemotherapy.
BJUI | 1988
Jenkins Bj; Mark J. Caulfield; C. G. Fowler; D. F. Badenoch; R. C. Tiptaft; A. M. I. Paris; H. F. Hope‐Stone; R. T. D. Oliver; J. P. Blandy
BJUI | 1989
G. R. Mufti; J. R. W. Gove; D. F. Badenoch; C. G. Fowler; R. C. Tiptaft; H. R. England; A. M. I. Paris; M. Singh; M. H. Hall; J. P. Blandy
BJUI | 1987
D. F. Badenoch; R. C. Tiptaft; D. R. Thakar; C. G. Fowler; J. P. Blandy
BJUI | 1997
R. Ravi; R.T.D. Oliver; J. Ong; D. F. Badenoch; C. G. Fowler; A.M.I. Paris; W.F. Hendry
BJUI | 1987
D. F. Badenoch; C. G. Fowler; B. J. Jenkins; J. V. Roberts; R. C. Tiptaft
BJUI | 1993
W. J. Lynch; D. F. Badenoch; O. J. McANENA
BJUI | 1992
B. J. Jenkins; D. F. Badenoch; C. G. Fowler; J. P. Blandy
Progress in Clinical and Biological Research | 1988
J. P. Blandy; Jenkins Bj; C. G. Fowler; Mark J. Caulfield; D. F. Badenoch; England Hr; H. F. Hope‐Stone; Mair Gm; Mantell Bs; R. T. D. Oliver